期刊文献+

Langerin在朗格汉斯细胞组织细胞增生症中的表达及诊断价值 被引量:9

Expression of Langerin in and its diagnostic value for Langerhans cell histiocytosis
下载PDF
导出
摘要 目的 Langerin是近年来新发现的朗格汉斯细胞标志物,能诱导朗格汉斯细胞内Birbeck颗粒的形成,对朗格汉斯细胞具有高度选择性。文中探讨Langerin在朗格汉斯细胞组织细胞增生症(Langerhans cell histiocytosis,LCH)的组织细胞中的表达及诊断价值。方法收集23例LCH和18例其他非LCH的组织细胞疾病(non-Langerhans cell histiocytic disorder,N-LCHD)的患者资料,进行病理组织学观察,免疫组织化学染色(EnVision法)检测Langerin、CD1a和S-100蛋白的表达。结果组织学显示23例LCH都有病理性朗格汉斯组织细胞增生,细胞呈卵圆形,较大,核不规则、有核沟和核折叠,核仁不明显,核膜薄,细胞质中等丰富,略呈嗜酸性,伴多量嗜酸性粒细胞浸润。免疫组织化学染色示LCH和N-LCHD中Langerin的表达率分别为100%和0%(P<0.05),CD1a的表达率分别为95.65%和5.6%(P<0.05),S-100蛋白的表达率分别为100%和72.2%。Langerin、CD1a和S-100蛋白对诊断LCH的敏感性分别为100%、95.65%和100%,特异性分别为100%、94.4%和27.8%。结论 Langerin是对诊断LCH高度敏感且特异的标志物,有助于LCH的诊断和鉴别诊断。 Objective Langerin is a newly discovered specific immunomarker of Langerhans cells, which plays a critical role in the formation of Birbeck granules. The aim of this study was to assess the specificity and utility of Langerin in the diagnosis of Langerhans cell histiocytosis (LCH). Methods We retrieved the data of 23 cases of LCH and 18 cases of various non- Langerhans cell histiocytic disorders (N-LCHD) from pathology files, and determined the expressions of Langerin, CDla and S-100 protein of both LCH and N-LCHD by pathohistological observation and immunohistochemical examination. Results Histologically, all the 23 cases of LCH showed proliferation of large oval ceils with indented, grooved or folded nuclei, inconspicuous nucleoli, thin nuclear membranes, and moderately abundant and slightly eosinophilic cytoplasm, accompanied by infiltration of variable numbers of eosinophils. The expressions of Langerin in LCH and N-LCHD were 100% and 0%, respectively (P 〈0.05), those of CDla were 95.65% and 5.6% (P 〈0.05), and those of S-100 protein were 100% and 72.2%. The sensitivities of Langerin, CDla and S-100 protein in the LCH group were 100%, 95.65% and 100%, and their specificities were 100%, 94.4% and 27.8%, respectively. Conclusion Langerin is a highly sensitive and specific immunomarker of LCH, and useful for the diagnosis and differential diagnosis of LCH.
出处 《医学研究生学报》 CAS 北大核心 2012年第7期694-698,共5页 Journal of Medical Postgraduates
基金 江苏省六大人才高峰重点课题基金(2007-B-022)
关键词 朗格汉斯细胞组织细胞增生症 LANGERIN 免疫组化 诊断 Langerhans cell histiocytosis Langerin Immunohistochemistry Diagnosis
  • 相关文献

参考文献2

二级参考文献18

  • 1Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumours. Pathology and genetics,tumours of haematopoietic and lymphoid tissues[M]. Lyon: IARC Press, 2001:278-89.
  • 2Jaffe ES. Surgical pathology of lymph nodes and related organs[M]. 2nd ed, Philadelphia: WB Saunders Co, 1995:560-93.
  • 3Falini B, Flenghi LO, Pileri S, et al. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage restricted form of the CD68 molecule[J]. Am J Pathol, 1993,142:1359-72.
  • 4Nezelof C, Bassert F. langerhans cell histiocytosis research, past, present, and future[J]. Hematol Oncol Clin North Am, 1998,12:385-406.
  • 5Copie-Bergman C, Wotherspoon AC, Norton AJ, et al. True histiocytic lymphoma: a morphologic, immunohistochemical, and molecular genetic study of 13 cases[J]. Am J Surg Pathol,1998,22:1386-92.
  • 6Cattoretti G, Villa A, Vezzoni P, et al. Malignant histiocytosis, a phenotypic and genotypic investigation[J]. Am J Pathol, 1990,136:1009-19.
  • 7Kamel OW, Gocke CD, Kell DL, et al. True histocytic lymphoma: a study of 12 cases based on current definition[J]. Leuk Lymoph, 1995,18:81-6.
  • 8Soria C,Orradre JL, Garcia-Almogro D, et al. True histiocytic lymphoma (monocytic sarcoma)[J]. Am J Dermatioathol,1992,14:511-7.
  • 9Vassallo R, Ryu JH,Colby TV, et al. Pulmonary Langerhans'-cell, histiocytosis[J]. N Engl J Med, 2000,342:1969-78.
  • 10Yu RC Chu AC. Lack of T-cell receptor gene rearrangements in cells involved in Langerthans cell histicoytosis[J]. Cancer, 1995,75:1162-6.

共引文献31

同被引文献70

引证文献9

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部